Macimorelin Acetate
No pricing data available yet for this peptide.
Pricing data is updated regularly.
Macimorelin is an orally active growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist. It stimulates pituitary growth hormone release by mimicking ghrelin's action on growth hormone secretagogue receptors. Unlike injectable GH secretagogues, macimorelin has excellent oral bioavailability and provides sustained GH release. It is FDA-approved as a diagnostic agent for adult growth hormone deficiency.
| Level | Amount | Frequency | Timing |
|---|---|---|---|
| Beginner | 0.25 mg/kg | Once daily | Oral, on empty stomach |
| Standard | 0.5 mg/kg | Once daily | Oral, fasting for 8 hours prior |
| Advanced | 0.5 mg/kg | Once daily | Oral, with monitoring of GH levels |
4-8 weeks for research protocols
Approximately 4-5 hours
Oral granule formulation dissolved in water (120mL) - not a traditional reconstitution
Store at room temperature (68-77°F), protect from moisture
Use within 30 minutes of dissolution
Explore peer-reviewed studies and clinical research on Macimorelin
Peer-reviewed medical research
Active and completed clinical trials
Academic papers and citations
Evidence-based supplement analysis
Research Disclaimer: These links lead to external research databases. Always consult with a qualified healthcare provider before making decisions based on research literature.
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Consult a licensed healthcare professional before using any peptide. BioProtocol does not sell peptides or pharmaceutical products.